1: Gaspard U, Taziaux M, Jost M, Coelingh Bennink HJT, Utian WH, Lobo RA, Foidart JM. A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life. Menopause. 2023 Feb 21. doi: 10.1097/GME.0000000000002167. Epub ahead of print. PMID: 36809193.
2: Gemzell-Danielsson Kristina, Cagnacci Angelo, Chabbert-Buffet Nathalie, Douxfils Jonathan, Foidart Jean-Michel, Kubba Ali, Lasa Luis Ignacio Lete, Mansour Diana, Neulen Joseph, Neves Jaoquim, Palma Fátima, Römer Thomas, Ski Robert Spaczy, Tóth Vera. A novel estetrol-containing combined oral contraceptive: European expert panel review. Ceska Gynekol. 2022;87(6):440-452. English. PMID: 36543594.
3: Douxfils J, Gaspard U, Taziaux M, Jost M, Bouvy C, Lobo RA, Utian WH, Foidart JM. Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women. Climacteric. 2023 Feb;26(1):55-63. doi: 10.1080/13697137.2022.2139599. Epub 2022 Nov 18. PMID: 36399023.
4: Zimmerman Y, Frydenberg M, van Poppel H, van Moorselaar RJA, Roos EPM, Somford DM, Roeleveld TA, de Haan TD, van Melick HHE, Reisman Y, Krijgh J, Debruyne FMJ, Coelingh Bennink HJT. Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study. Eur Urol Open Sci. 2022 Oct 3;45:59-67. doi: 10.1016/j.euros.2022.09.006. PMID: 36353657; PMCID: PMC9637725.
5: Chen MJ, Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Archer DF, Jost M, Foidart JM, Creinin M. Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials. Contraception. 2022 Dec;116:44-50. doi: 10.1016/j.contraception.2022.10.004. Epub 2022 Oct 17. PMID: 36257374.
6: Douxfils J, Morimont L, Gaspard U, Utian WH, Foidart JM. Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation. Thromb Res. 2022 Sep 16:S0049-3848(22)00387-5. doi: 10.1016/j.thromres.2022.09.007. Epub ahead of print. PMID: 36130859.
7: Morimont L, Jost M, Gaspard U, Foidart JM, Dogné JM, Douxfils J. Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone. J Clin Endocrinol Metab. 2022 Dec 17;108(1):135-143. doi: 10.1210/clinem/dgac511. PMID: 36099501; PMCID: PMC9759169.
8: Lee A, Syed YY. Correction: Estetrol/Drospirenone: A Review in Oral Contraception. Drugs. 2022 Aug;82(12):1341. doi: 10.1007/s40265-022-01760-w. Erratum for: Drugs. 2022 Jul;82(10):1117-1125. PMID: 35945474; PMCID: PMC9499896.
9: Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Jensen JT, Westhoff CL, Jost M, Foidart JM, Creinin MD. Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women. Contraception. 2022 Dec;116:29-36. doi: 10.1016/j.contraception.2022.07.010. Epub 2022 Aug 1. PMID: 35921872.
10: Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Chen MJ, Apter D, Jost M, Foidart JM, Creinin MD. Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials. Contraception. 2022 Dec;116:37-43. doi: 10.1016/j.contraception.2022.07.009. Epub 2022 Jul 31. PMID: 35921870.
11: Gemzell-Danielsson K, Cagnacci A, Chabbert-Buffet N, Douxfils J, Foidart JM, Kubba A, Lete Lasa LI, Mansour D, Neulen J, Neves J, Palma F, Römer T, Spaczyński R, Tóth V. A novel estetrol-containing combined oral contraceptive: European expert panel review. Eur J Contracept Reprod Health Care. 2022 Oct;27(5):373-383. doi: 10.1080/13625187.2022.2093850. Epub 2022 Jul 21. PMID: 35862627.
12: Lee A, Syed YY. Estetrol/Drospirenone: A Review in Oral Contraception. Drugs. 2022 Jul;82(10):1117-1125. doi: 10.1007/s40265-022-01738-8. Epub 2022 Jul 4. Erratum in: Drugs. 2022 Aug;82(12):1341. PMID: 35781795; PMCID: PMC9363382.
13: Gérard C, Arnal JF, Jost M, Douxfils J, Lenfant F, Fontaine C, Houtman R, Archer DF, Reid RL, Lobo RA, Gaspard U, Coelingh Bennink HJT, Creinin MD, Foidart JM. Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause. Expert Rev Clin Pharmacol. 2022 Feb;15(2):121-137. doi: 10.1080/17512433.2022.2054413. Epub 2022 Mar 27. PMID: 35306927.
14: Paton DM. Estetrol and drospirenone: a novel oral contraceptive. Drugs Today (Barc). 2022 Jan;58(1):1-8. doi: 10.1358/dot.2022.58.1.3353167. PMID: 35107089.
15: Fruzzetti F, Fidecicchi T, Montt Guevara MM, Simoncini T. Estetrol: A New Choice for Contraception. J Clin Med. 2021 Nov 29;10(23):5625. doi: 10.3390/jcm10235625. PMID: 34884326; PMCID: PMC8658652.
16: Gallez A, Dias Da Silva I, Wuidar V, Foidart JM, Péqueux C. Estetrol and Mammary Gland: Friends or Foes? J Mammary Gland Biol Neoplasia. 2021 Sep;26(3):297-308. doi: 10.1007/s10911-021-09497-0. Epub 2021 Aug 31. PMID: 34463898; PMCID: PMC8566418.
17: Coelingh Bennink HJT, van Moorselaar JA, Crawford ED, Roos EPM, Somford DM, Roeleveld TA, de Haan TD, van Melick HHE, Reisman Y, Zimmerman Y, van Osta G, Krijgh J, Shore ND, Saad F, Schally AV, Debruyne FMJ. Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi). Eur Urol Open Sci. 2021 May 6;28:52-61. doi: 10.1016/j.euros.2021.04.005. PMID: 34337526; PMCID: PMC8317802.
18: Gemzell-Danielsson K, Apter D, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Jost M, Creinin MD, Foidart JM. Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia. BJOG. 2022 Jan;129(1):63-71. doi: 10.1111/1471-0528.16840. Epub 2021 Aug 9. PMID: 34245666; PMCID: PMC9290720.
19: Estetrol/drospirenone (Nextstellis) - a new combination oral contraceptive. Med Lett Drugs Ther. 2021 Jun 28;63(1627):101-102. PMID: 34181632.
20: Křepelka Petr. Estetrol and the possibilities of its clinical use. Ceska Gynekol. 2021;86(3):217-221. English. doi: 10.48095/cccg2021217. PMID: 34167315.